Travoprost Ophthalmic Solution
Product Images NDC 71335-2738

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic (NDC 71335-2738). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (713352738 E Label)

This product contains inactive ingredients including polyoxyl 40 hydrogenated castor oil, boric acid, propylene glycol, sorbitol, zinc chloride, sodium hydroxide, and water for Injection USP. Additionally, hydrochloric acid may be used to adjust the pH of the solution.*

FDA Label Image

Label (Lbl713352738)

Each milliliter of FH contains 0.04mg of active ingredient Travoprost. The usual dosage is to put one drop in the affected eye(s) once a day in the evening. It is important to scan the package insert QR code for additional information. The solution is preserved with an ionic buffered system. This package is not child-resistant, so it should be kept out of reach of children. Store between 2°-25°C (36°-77°F) and use in the eyes only. This product is relabeled by Bryant Ranch Prepack, Inc and manufactured by Micro Labs Limited.*

FDA Label Image

Travoprost-figa.jpg (Travoprost Figa)

FDA Label Image

Travoprost-figb.jpg (Travoprost Figb)

FDA Label Image

Travoprost-figc.jpg (Travoprost Figc)

FDA Label Image

Travoprost-str.jpg (Travoprost Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.